Clinuvel Pharmaceuticals (ASX:CUV) has received a notice of change of interests of substantial holder from JPMorgan Chase & Co. and its affiliates, disclosing that the financial institution's voting power in the company increased from 6.53% to 7.96%, with the change recorded on 12 November 2026.
Key Points
- JPMorgan Chase & Co. and its affiliates held 4,017,650 ordinary shares, representing 7.96% voting power, as of 12 November 2026.
- The previous notice, dated 1 October 2026, disclosed 3,295,154 ordinary shares at 6.53% voting power.
- Changes in relevant interests involved multiple JPMorgan affiliates including JPMorgan Chase Bank N.A., J.P. Morgan Securities PLC, J.P. Morgan Securities LLC, J.P. Morgan Securities Australia Limited, and J.P. Morgan Prime Inc.
- Securities are held across various arrangements including securities lending agreements, rehypothecation under prime brokerage agreements, and principal/proprietary purchases and sales.
Voting Power Change Between October and November 2026
According to the Form 604 filing lodged with Clinuvel Pharmaceuticals, JPMorgan Chase & Co. and its affiliates held 3,295,154 ordinary shares representing 6.53% voting power at the time of the previous notice, dated 1 October 2026. As of 12 November 2026, the total number of ordinary shares in which the substantial holder and its associates held a relevant interest stood at 4,017,650, equating to 7.96% voting power. The previous notice was given to the company on 5 October 2026.
Changes Across JPMorgan Affiliates
The filing details changes across several JPMorgan affiliates. JPMorgan Chase Bank N.A. recorded a change involving 673,109 ordinary shares in its capacity as agent lender for securities on loan. J.P. Morgan Securities PLC reported a change of 41,521 ordinary shares held subject to an obligation to return under a securities lending agreement. J.P. Morgan Securities LLC recorded changes of 13,800 ordinary shares under a securities lending agreement and 736 ordinary shares via rehypothecation under a prime brokerage agreement. J.P. Morgan Securities Australia Limited reported changes of 9,598 ordinary shares under a securities lending agreement and 31,062 ordinary shares through principal/proprietary purchases and sales. J.P. Morgan Prime Inc. reported a change of 534 ordinary shares via rehypothecation under a prime brokerage agreement.
Present Relevant Interests Held Across Multiple Arrangements
Following the change, the filing sets out present relevant interests across multiple holders and arrangements. JPMorgan Chase Bank N.A. holds 1,386,402 ordinary shares as agent lender for securities on loan. J.P. Morgan Securities PLC holds a combined 713,552 ordinary shares across a securities lending arrangement and principal/proprietary capacity. J.P. Morgan Securities LLC holds a total of 1,316,343 ordinary shares across lending, rehypothecation, and proprietary arrangements. J.P. Morgan Securities Australia Limited holds 583,083 ordinary shares across lending and proprietary capacities. J.P. Morgan Prime Inc. holds 503 ordinary shares via rehypothecation, and J.P. Morgan Investment Management Inc. holds 17,767 ordinary shares in its capacity as investment manager.




Please wait processing your request...